SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 154 0 LGND
Emcee:  Henry Niman Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
29984 Henry, Thanks for the clarification regarding the use of Targretin as a first Torben Noerup Nielsen-1/8/2000
29983 Oral Targretin was approved as a second line treatment because CTCL is typicallHenry Niman-1/8/2000
29982 Celery, Mathematics - including Statistics - was my first Great Love (that wasTorben Noerup Nielsen-1/8/2000
29981 funny i was just ready good old Dr. Simon's remarks >)celeryroot.com-1/8/2000
29980 Who is this Dr. Simon? He seems to have a fixation with statistics. Suppose I wTorben Noerup Nielsen-1/8/2000
29979 Henry, Thanks for sharing this information. I found it fascinating reading and Arthur Radley-1/8/2000
29978 I believe you are correct; pricing is somehow figured into the approval processbuyhiman-1/8/2000
29977 Yes Walter, many saw their quality of life improve, even if they didn't makHenry Niman-1/8/2000
29976 Henry, this is really interesting. So we have two groups, those that respondedWTDEC-1/8/2000
29975 Targretin Package Insert is at fda.gov (75 mg soft gel capsules) Henry Niman-1/8/2000
29974 Walter, I think that the testimonials give a much better feel for what the patiHenry Niman-1/8/2000
29973 This would seem to suggest starting Targretin *before* using Interferon Alpha. Torben Noerup Nielsen-1/8/2000
29972 Oops; you cannot break gel tablets I guess :-)Torben Noerup Nielsen-1/8/2000
29971 Here's the NEJM abstract on Targretin (bexarotene) and hypothyroidism in CTHenry Niman-1/8/2000
29970 Word is starting to get out (it's almost a Ligand infomercial :-)): DermatHenry Niman-1/8/2000
29969 Yes, they are dose related and actually the hypothyroidism is largely restricteHenry Niman-1/8/2000
29968 Torben, Plaque psoriasis is a MAJOR consideration. I think that many MDs know Henry Niman-1/8/2000
29967 Henry, If the drug has even a reasonable chance of retarding tumor growth, patTorben Noerup Nielsen-1/8/2000
29966 Henry, It appears that the main side effects are increase in triglycerides andpsh-1/8/2000
29965 Is not immunosuppresive and is not mutagenic. This message needs to get out. notyet-1/8/2000
29964 Henry, thanks for posting the stories. Stockholders should feel good about LGNWTDEC-1/8/2000
29963 I agree that these are sad stories, with almost "miraculous" results Henry Niman-1/8/2000
29962 henry, wow. what sad stories. i'm glad lgnd was able to help this people Skeeter Bug-1/8/2000
29961 More case studies: I'd now like to introduce Dr. Madeleine Duvic from the MHenry Niman-1/8/2000
29960 Two case studies: DR. HYMES: Good morning. Thank you, Dr. Reich. I'd likHenry Niman-1/8/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):